Products and Services

Products and Services

Active Pharmaceutical Ingredients


Ausun

Product Name

CAS Number

Specification

DMF

CEP

Status

CN

PV

Ramelteon

196597-26-9

In-house

Pilocarpine Hydrochloride

54-71-7

USP, EP, JP

CEP2023- 367-Rev 00

Sitafloxacin Hydrate

163253-35-8

In-house

Sugammadex Sodium

343306-79-6

In-house

Tasimelteon

609799-22-6

In-house

Ticagrelor

274693-27-5

EP, In-house

R0-CEP 2021-081- Rev 00

Resmetirom

920509-32-6

In-house

Q4 2025

Bimatoprost

155206-00-1

In-house

Q3 2025

Latanoprost

130209-82-4

USP, EP

CEP2022-174-Rev 00

Lubiprostone

333963-40-9

In-house

Tafluprost

209860-87-7

In-house

Travoprost

157283-68-6

USP, In-house

Abemaciclib

1231929-97-7

In-house

Q4 2025

Alectinib

1256580-46-7

In-house

Q4 2025

Binimetinib

606143-89-9

In-house

Q4 2025

Cabozantinib

849217-68-1

In-house

Q4 2025

Dabrafenib mesylate

1195768-06-9

In-house

Q4 2025

Imatinib Mesylate

220127-57-1

EP, In-house

CEP2023- 303-Rev 00

Lenvatinib Mesylate

857890-39-2

In-house

Olaparib

763113-22-0

In-house